The Unresolved Challenge in Primary Prevention Cardiovascular diseases (CVDs), principally ischemic heart disease and stroke, ...

In the past, doctors advised older patients to take low daily doses of aspirin to “thin the blood.” This was meant to reduce ...

The hypothesis that low-dose aspirin might eventually lower cancer risk after years of use appears unsupported in adults aged 70 years or older, according to new long-term data from the ASPREE trial.

Researchers conducted a cross-sectional study to evaluate whether negative messaging about aspirin for primary prevention affected its use for secondary prevention. They included data from 1890 ...

For decades, many older adults popped a baby aspirin daily in an effort to lower their risk of heart attack and heart disease in general. The idea was that baby aspirin makes blood platelets less ...

Daily aspirin use does not offer a quick or reliable way to prevent bowel cancer in the general population and carries immediate risks of serious bleeding, a new Cochrane review finds. Bowel cancer, ...

Aspirin after an initial short course of rivaroxaban has been shown to be safe and effective for the prevention of venous thromboembolism after total hip or total knee arthroplasty, but uncertainty ...

The American College of Cardiology released a 2026 scientific statement on antiplatelet therapy for atherosclerotic cardiovascular disease.